Improving Safety of Transitions to Skilled Nursing Care Using Videoconferencing (ECHO-CT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03832257|
Recruitment Status : Active, not recruiting
First Posted : February 6, 2019
Last Update Posted : December 16, 2022
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Acute Disease||Other: ECHO CT Intervention Other: Matched Non-Participating Facilities||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||800 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||AHRQ Health Services Research Projects: Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities|
|Actual Study Start Date :||September 30, 2018|
|Estimated Primary Completion Date :||August 31, 2023|
|Estimated Study Completion Date :||August 31, 2023|
Experimental: ECHO CT Intervention
Weekly video conference between hospitalist at Beth Israel and skilled nursing facilities.
Other: ECHO CT Intervention
weekly video conference between hospitalist and skilled nursing facilities
Matched Non- Participating Facilities
Matched non-participating facilities
Other: Matched Non-Participating Facilities
Matched Non-Participating Facilities
- 30-Day Readmission Rates [ Time Frame: 30-Days ]Number of hospital readmissions over 30 day period among participating SNF sites
- Health Care Utilization [ Time Frame: up to 90 days ]Includes average length of stay in the facility
- Health Care Cost [ Time Frame: 30-days ]Total 30-day Medicare costs for fee-for-service patients.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||65 Years and older (Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
Facility Inclusion Criteria:
- SNF receives approximately the middle third of referral volume (approx. 20-100 referrals/ average 40 per year)
- SNF not so highly engaged with acute hospital that their patients are less likely to benefit from the intervention.
- SNF affiliated with BIDMC Boston or BIDMC Needham
Facility Exclusion Criteria:
- Has not recently participated in ECHO CT
- Do not send anyone to ECHO CT training
- Clinicians are unwilling to make a commitment to attend at least 75% of video conferences
Inclusion Criteria: Patients that were discharged from BIDMC and admitted to skilled nursing facilities that are participating in ECHO-CT between April 2019 and March 2021.
Exclusion Criteria: Patients discharged from a hospital other than BIDMC. Patients admitted to a skilled nursing facility that is not participating in ECHO-CT.
Inclusion Criteria: Patients from skilled nursing facilities not participating in ECHO.
Exclusion Criteria: Patients discharged from BIDMC to one of our participating SNFs during the study period of April 2019- March 2021
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03832257
|United States, Massachusetts|
|Beth Israel Deaconess Medical Center|
|Boston, Massachusetts, United States, 02215|
|Responsible Party:||Lewis Lipsitz, Professor of Medicine, Beth Israel Deaconess Medical Center|
|Other Study ID Numbers:||
|First Posted:||February 6, 2019 Key Record Dates|
|Last Update Posted:||December 16, 2022|
|Last Verified:||December 2022|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|